Avicenna.ai is a technology company.
Avicenna.ai has raised $11.0M across 2 funding rounds.
Avicenna.ai has raised $11.0M in total across 2 funding rounds.
Avicenna.ai has raised $11.0M in total across 2 funding rounds.
Avicenna.ai's investors include Innovacom, Bruno Maisonnier.
Avicenna.AI is a technology company specializing in artificial intelligence solutions for emergency radiology. It develops AI-powered tools that assist radiologists by automating the detection and prioritization of urgent cases in CT scans, thereby accelerating diagnosis and improving patient outcomes. Its products serve hospitals, healthcare networks, and teleradiology groups by integrating seamlessly into existing radiology workflows to optimize efficiency and resource allocation in emergency imaging[1][2][3][4].
Founded by experts combining medical and software engineering knowledge, Avicenna.AI emerged from the need to reduce radiologists' manual workload and improve triage accuracy in emergency settings. Early traction came from its ability to deliver fast, reliable AI insights that prioritize critical cases without disrupting clinical workflows. The company has since evolved to launch the AVI platform, which enables plug-and-play integration of multiple AI imaging applications, enhancing scalability and ease of deployment across healthcare systems[1][2][7].
Avicenna.AI rides the growing trend of AI adoption in healthcare, particularly in medical imaging where demand for faster, more accurate diagnostics is rising due to increasing imaging volumes and clinician shortages. The timing is critical as healthcare systems worldwide seek scalable, cost-effective AI solutions that integrate smoothly into existing infrastructures. Avicenna.AI’s focus on emergency radiology addresses a high-impact niche where timely diagnosis can significantly affect patient outcomes. Their platform approach also supports the broader ecosystem by enabling multiple AI applications to coexist and scale within healthcare networks[2][3][7].
Looking ahead, Avicenna.AI is positioned to expand its AI platform capabilities and portfolio of imaging applications, potentially broadening into other radiology domains beyond emergency care. Trends such as increased AI regulatory clarity, growing acceptance of AI in clinical decision-making, and healthcare digitization will shape its trajectory. The company’s emphasis on seamless integration and regulatory compliance will likely enhance adoption and influence in the medical imaging AI market, contributing to faster, more efficient radiology services globally[2][5][7]. This aligns with their mission to revolutionize care through AI-driven radiology solutions that improve patient outcomes and healthcare efficiency.
Avicenna.ai has raised $11.0M across 2 funding rounds. Most recently, it raised $8.0M Series A in February 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2023 | $8.0M Series A | Innovacom, Bruno Maisonnier | |
| Feb 1, 2020 | $3.0M Seed | Innovacom, Bruno Maisonnier |